相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Computational investigations of gram-negative bacteria phosphopantetheine adenylyltransferase inhibitors using 3D-QSAR, molecular docking and molecular dynamic simulations
Ying Wang et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies
Nayera W. Hassan et al.
BIOORGANIC CHEMISTRY (2020)
Adipostatins E-J, new potent antimicrobials identified as inhibitors of coenzyme-A biosynthesis
Lyanne Gomez-Rodriguez et al.
TETRAHEDRON LETTERS (2020)
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
Qingan Sun et al.
NATURE COMMUNICATIONS (2020)
Pyrazinamide triggers degradation of its target aspartate decarboxylase
Pooja Gopal et al.
NATURE COMMUNICATIONS (2020)
Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents
Singireddi Srinivasarao et al.
RSC ADVANCES (2020)
Design, synthesis and molecular docking studies of quinazolin-4-ones linked to 1,2,3-triazol hybrids as Mycobacterium tuberculosis H37Rv inhibitors besides antimicrobial activity
Narendra Kumar Maddali et al.
MEDICINAL CHEMISTRY RESEARCH (2019)
Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
Elaine Ballinger et al.
SCIENCE (2019)
Structural insights into Escherichia coli phosphopantothenoylcysteine synthetase by native ion mobility-mass spectrometry
Daniel Shiu-Hin Chan et al.
BIOCHEMICAL JOURNAL (2019)
Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum
Joost Schalkwijk et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Crystallographic Analysis of the Catalytic Mechanism of Phosphopantothenoylcysteine Synthetase from Saccharomyces cerevisiae
Peiyi Zheng et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide
Pooja Gopal et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Inhibition of Pantothenate Synthetase by Analogs of β-Alanine Precursor Ineffective as an Antibacterial Strategy
S. Imindu Liyanage et al.
CHEMOTHERAPY (2019)
'Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.' plus Do we have enough pieces to solve the pyrazinamide puzzle?
R. M. Anthony et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
Robert J. Moreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity
Colin K. Skepper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis
Francesc Coll et al.
NATURE GENETICS (2018)
Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis
Ninad V. Puranik et al.
RSC ADVANCES (2018)
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
Laurent R. Chiarelli et al.
SCIENTIFIC REPORTS (2018)
Alanine mutation of the catalytic sites of Pantothenate Synthetase causes distinct conformational changes in the ATP binding region
Bharati Pandey et al.
SCIENTIFIC REPORTS (2018)
The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis
Xu Wang et al.
ACS INFECTIOUS DISEASES (2018)
The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
Samantha Wellington et al.
ACS INFECTIOUS DISEASES (2018)
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity
Caroline Giessner et al.
LIFE SCIENCE ALLIANCE (2018)
Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
Jim Werngren et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Identification and development of pyrazolo[4,3-c]pyridine carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Suresh Amaroju et al.
NEW JOURNAL OF CHEMISTRY (2017)
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
Michael A. DeJesus et al.
MBIO (2017)
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
Adam N. Yadon et al.
NATURE COMMUNICATIONS (2017)
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
Marta Esposito et al.
ACS INFECTIOUS DISEASES (2017)
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase CIpC1
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2017)
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2017)
Biochemical and structural studies of mutants indicate concerted movement of the dimer interface and ligand-binding region of Mycobacterium tuberculosis pantothenate kinase
A. Paul et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2017)
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
Yoshiyuki Yamada et al.
MSPHERE (2017)
Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model
Claire M. Naftalin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Virtual screening of selective inhibitors of phosphopantetheine adenylyltransferase from Mycobacterium tuberculosis
D. D. Podshivalov et al.
CRYSTALLOGRAPHY REPORTS (2017)
Biochemical characterization of a new mitochondrial transporter of dephosphocoenzyme A in Drosophila melanogaster
Angelo Vozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis
Alvin W. Hung et al.
CHEMMEDCHEM (2016)
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis
Jean-Philippe Lanoix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives
Kalaga Mahalakshmi Naidu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Coenzyme A: to make it or uptake it?
Ody C. M. Sibon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis
Joanna C. Evans et al.
ACS INFECTIOUS DISEASES (2016)
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2016)
Acetyl Coenzyme A: A Central Metabolite and Second Messenger
Federico Pietrocola et al.
CELL METABOLISM (2015)
Extracellular 4′-phosphopantetheine is a source for intracellular coenzyme A synthesis
Balaji Srinivasan et al.
NATURE CHEMICAL BIOLOGY (2015)
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960
Dmitry A. Maslov et al.
TUBERCULOSIS (2015)
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
Laura E. Via et al.
ACS INFECTIOUS DISEASES (2015)
Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors
B. K. Kishore Reddy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide
Nicholas A. Dillon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Recent advances in targeting coenzyme A biosynthesis and utilization for antimicrobial drug development
Wessel J. A. Moolman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads
Ganesh Samala et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase
Zhixiang Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Structure-Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors
Parthiban Brindha Devi et al.
CHEMMEDCHEM (2014)
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives
Kalaga Mahalakshmi Naidu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Variation in pantothenate kinase type determines the pantothenamide mode of action and impacts on coenzyme A salvage biosynthesis
Marianne de Villiers et al.
FEBS JOURNAL (2014)
Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis
Fidele Ntie-Kang et al.
MOLECULAR BIOSYSTEMS (2014)
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
Wanliang Shi et al.
EMERGING MICROBES & INFECTIONS (2014)
Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy
Boudewijn L. M. de Jonge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis
Olga T. Schubert et al.
CELL HOST & MICROBE (2013)
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors
Ganesh Samala et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Replacing sulfa drugs with novel DHPS inhibitors
Dalia I. Hammoudeh et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Speculative strategies for new antibacterials: all roads should not lead to Rome
Stuart Shapiro
JOURNAL OF ANTIBIOTICS (2013)
Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase
Christofer Bjorkelid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Experimentally Validated Novel Inhibitors of Helicobacter pylori Phosphopantetheine Adenylyltransferase Discovered by Virtual High-Throughput Screening
Chao-Sheng Cheng et al.
PLOS ONE (2013)
A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis
Anuradha Kumar et al.
PLOS ONE (2013)
Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery
Hernani Leonardo Silvestre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Shuo Zhang et al.
EMERGING MICROBES & INFECTIONS (2013)
X-ray study of the conformational changes in the molecule of phosphopantetheine adenylyltransferase from Mycobacterium tuberculosis during the catalyzed reaction
Vladimir Timofeev et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)
The Antibiotic CJ-15,801 Is an Antimetabolite that Hijacks and Then Inhibits CoA Biosynthesis
Renier van der Westhuyzen et al.
CHEMISTRY & BIOLOGY (2012)
Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening
Garth L. Abrahams et al.
CHEMISTRY & BIOLOGY (2012)
Three-Dimensional Structure of Phosphopantetheine Adenylyltransferase from Mycobacterium Tuberculosis in the Apo Form and in Complexes with Coenzyme A and Dephosphocoenzyme A
V. I. Timofeev et al.
CRYSTALLOGRAPHY REPORTS (2012)
Bacterial proteolytic complexes as therapeutic targets
Ravikiran M. Raju et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Chemoinformatic Identification of Novel Inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase
Reetu Sharma et al.
PLOS ONE (2012)
Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate α-Decarboxylase Using Nuclear Magnetic Resonance (1H NMR)
Reetu Sharma et al.
PLOS ONE (2012)
Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targets
Anisha Ambady et al.
TUBERCULOSIS (2012)
Screening, Identification, and Characterization of Mechanistically Diverse Inhibitors of the Mycobacterium Tuberculosis Enzyme, Pantothenate Kinase (CoaA)
Janani Venkatraman et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Location and conformation of pantothenate and its derivatives in Mycobacterium tuberculosis pantothenate kinase: insights into enzyme action
Bhaskar Chetnani et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Structure of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase in complex with the feedback inhibitor CoA reveals only one active-site conformation
T. Wubben et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2011)
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition
Yanhui Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification of Critical Residues of the Mycobacterial Dephosphocoenzyme A Kinase by Site-Directed Mutagenesis
Guneet Walia et al.
PLOS ONE (2011)
Insights into the Regulatory Characteristics of the Mycobacterial Dephosphocoenzyme A Kinase: Implications for the Universal CoA Biosynthesis Pathway
Guneet Walia et al.
PLOS ONE (2011)
Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier
Kyu Y. Rhee et al.
TRENDS IN MICROBIOLOGY (2011)
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
Jennifer E. Griffin et al.
PLOS PATHOGENS (2011)
The Use of Biochemical and Biophysical Tools for Triage of High-Throughput Screening Hits - A Case Study with Escherichia coli Phosphopantetheine Adenylyltransferase
J. Richard Miller et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
3-Fluoroaspartate and Pyruvoyl-Dependant Aspartate Decarboxylase: Exploiting the Unique Characteristics of Fluorine To Probe Reactivity and Binding
Jandre de Villiers et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Preparation of the Crystal Complex of Phosphopantetheine Adenylyltransferase from Mycobacterium tuberculosis with Coenzyme A and Investigation of Its Three-Dimensional Structure at 2.1-Resolution
V. I. Timofeev et al.
CRYSTALLOGRAPHY REPORTS (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
M. tuberculosis Pantothenate Kinase: Dual Substrate Specificity and Unusual Changes in Ligand Locations
Bhaskar Chetnani et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Kinetic, Thermodynamic, and Structural Insight into the Mechanism of Phosphopantetheine Adenylyltransferase from Mycobacterium tuberculosis
Thomas J. Wubben et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase
Pawel Sledz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis
Disha Awasthy et al.
MICROBIOLOGY-SGM (2010)
Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action
Bhaskar Chetnani et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase
Alvin W. Hung et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Selective Inhibitors of Bacterial Phosphopantothenoylcysteine Synthetase
James D. Patrone et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
The Role of UPF0157 in the Folding of M-tuberculosis Dephosphocoenzyme A Kinase and the Regulation of the Latter by CTP
Guneet Walia et al.
PLOS ONE (2009)
targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis
Karthik Raman et al.
BMC SYSTEMS BIOLOGY (2008)
Inhibition of Mycobacterium tuberculosis Pantothenate Synthetase by Analogues of the Reaction Intermediate
Alessio Ciulli et al.
CHEMBIOCHEM (2008)
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase:: Initiating a quest for new antitubercular drugs
Subash Velaparthi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Coenzyme A biosynthesis: an antimicrobial drug target
Christina Spry et al.
FEMS MICROBIOLOGY REVIEWS (2008)
How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis
Parimal Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Crystal structure of Escherichia coli ketopantoate reductase in a ternary complex with NADP+ and pantoate bound -: Substrate recognition, conformational change, and cooperativity
Alessio Ciulli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase
E. Lucile White et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
The ubiquitous carrier protein - a window to metabolite biosynthesis
Andrew C. Mercer et al.
NATURAL PRODUCT REPORTS (2007)
Crystal structure of uncleaved L-aspartate-α-decarboxylase from Mycobacterium tuberculosis
Gayathri Gopalan et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Probing hot spots at protein-ligand binding sites: A fragment-based approach using biophysical methods
Alessio Ciulli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Invariance and variability in bacterial PanK:: a study based on the crystal structure of Mycobacterium tuberculosis PanK
Satyabrata Das et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis snapshots of the enzyme in action
SS Wang et al.
BIOCHEMISTRY (2006)
The crystal structure of Escherichia coli ketopantoate reductase with NADP+ bound
CMC Lobley et al.
BIOCHEMISTRY (2005)
Characterization of a new pantothenate kinase isoform from Helicobacter pylori.
LA Brand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Coenzyme A: Back in action
R Leonardi et al.
PROGRESS IN LIPID RESEARCH (2005)
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of pantothenate kinase from Mycobacterium tuberculosis
S Das et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
Substrate-induced asymmetry and channel closure revealed by the apoenzyme structure of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase
VK Morris et al.
PROTEIN SCIENCE (2004)
Mechanistic studies on phosphopantothenoylcysteine decarboxylase: Trapping of an enethiolate intermediate with a mechanism-based inactivating agent
E Strauss et al.
BIOCHEMISTRY (2004)
Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate
RJ Zheng et al.
BIOCHEMISTRY (2004)
Structural basis of CTP-dependent peptide bond formation in coenzyme A biosynthesis catalyzed by Escherichia coli PPC synthetase
S Stanitzek et al.
STRUCTURE (2004)
Biosynthesis of pantothenate
ME Webb et al.
NATURAL PRODUCT REPORTS (2004)
Unusual space-group pseudosymmetry in crystals of human phosphopantothenoylcysteine decarboxylase
N Manoj et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2003)
Substrate specificity and kinetic isotope effect analysis of the Eschericia coli ketopantoate reductase
RJ Zheng et al.
BIOCHEMISTRY (2003)
Structure of human phosphopantothenoylcysteine synthetase at 2.3 Å resolution
N Manoj et al.
STRUCTURE (2003)
The crystal structure of the first enzyme in the pantothenate biosynthetic pathway, ketopantoate hydroxymethyltransferase, from M-tuberculosis
BN Chaudhuri et al.
STRUCTURE (2003)
Crystal structures of a pantothenate synthetase from M-tuberculosis and its complexes with substrates and a reaction intermediate
SS Wang et al.
PROTEIN SCIENCE (2003)
Inhibitors of phosphopantetheine adenylyltransferase
LH Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Mycobacterium tuberculosis ketopantoate hydroxymethyltransferase:: Tetrahydrofolate-independent hydroxymethyltransferase and enolization reactions with α-keto acids
M Sugantino et al.
BIOCHEMISTRY (2003)
A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis
VK Sambandamurthy et al.
NATURE MEDICINE (2002)
Molecular characterization of the 4′-phosphopantothenoylcysteine synthetase domain of bacterial Dfp flavoproteins
T Kupke
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD
S Chopra et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Identification and characterization of the gene encoding the human phosphopantetheine adenylyltransferase and dephospho-CoA kinase bifunctional enzyme (CoA synthase)
S Aghajanian et al.
BIOCHEMICAL JOURNAL (2002)
Molecular cloning of CoA synthase - The missing link in CoA biosynthesis
A Zhyvoloup et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics
M Daugherty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Elevated levels of ketopantoate hydroxymethyltransferase (panB) lead to a physiologically significant coenzyme a elevation in Salmonella enterica serovar typhimurium
A Rubio et al.
JOURNAL OF BACTERIOLOGY (2002)
Crystal structure of Escherichia coli ketopantoate reductase at 1.7 Å resolution and insight into the enzyme mechanism
D Matak-Vinkovic et al.
BIOCHEMISTRY (2001)
CJ-15,801, a novel antibiotic from a fungus, Seimatosporium sp.
Y Sugie et al.
JOURNAL OF ANTIBIOTICS (2001)
Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase
RJ Zheng et al.
BIOCHEMISTRY (2001)
Quantification of intracellular metabolites in Escherichia coli K12 using liquid chromatographic-electrospray ionization tandem mass spectrometric techniques
A Buchholz et al.
ANALYTICAL BIOCHEMISTRY (2001)
Identification of active site residues in E-coli ketopantoate reductase by mutagenesis and chemical rescue
RJ Zheng et al.
BIOCHEMISTRY (2000)
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
AE DeBarber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Kinetic and mechanistic analysis of the E-coli panE-encoded ketopantoate reductase
RJ Zheng et al.
BIOCHEMISTRY (2000)
分享论文
